OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 16 filers reported holding OPIANT PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $198,000 | +7.0% | 15,100 | +17.6% | 0.01% | -30.8% |
Q4 2018 | $185,000 | -5.1% | 12,835 | +17.0% | 0.01% | +18.2% |
Q3 2018 | $195,000 | +2.1% | 10,968 | +9.7% | 0.01% | -8.3% |
Q1 2018 | $191,000 | -59.2% | 10,000 | -51.0% | 0.01% | -52.0% |
Q4 2017 | $468,000 | -8.4% | 20,400 | +46.8% | 0.02% | -7.4% |
Q3 2017 | $511,000 | – | 13,900 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 80,000 | $850,000 | 0.77% |
PERRITT CAPITAL MANAGEMENT INC | 32,000 | $340,000 | 0.18% |
Newbridge Financial Services Group, Inc. | 5,300 | $56,000 | 0.04% |
Mesirow Financial Investment Management, Inc. | 753 | $8,000 | 0.02% |
Marquette Asset Management, LLC | 7,941 | $84,000 | 0.02% |
Renaissance Technologies | 222,815 | $2,366,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 59,831 | $635,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 10,400 | $110,000 | 0.00% |
American Research & Management Co. | 300 | $3,000 | 0.00% |
Certified Advisory Corp | 500 | $5,000 | 0.00% |